Products

Biocell - High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable

    • Product Name: Biocell - High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: sales10@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    VTB
    Specifications
    HS Code 197200
    Product Name Biocell - High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable
    Brand Biocell
    Product Type Flexible Bag
    Material Pharma-grade multilayer polymer film
    Grade Pharma Grade
    Primary Function Bioproducts Preservation
    Application API storage, transport, and preservation
    Compatible Dosage Forms Tablet, Capsule, Granule, Injection, Oral, Injectable
    Barrier Properties High barrier against moisture, oxygen, and light
    Sterilization Compatibility Gamma irradiation, ethylene oxide, and autoclave compatible
    Capacity Range 1 L to 1000 L
    Closure Type Sterile connector, screw cap, or aseptic weld
    Regulatory Compliance USP Class VI, ISO 10993, GMP, and FDA compliant
    Storage Conditions Clean, dry environment at controlled room temperature
    Shelf Life Up to 5 years
    Customization Available in custom sizes, ports, and labeling
    Sealing Type Heat sealed and leak-proof
    Temperature Range -20°C to 50°C

    As an accredited Biocell - High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in high-quality flexible bags, 25 kg per bag, ensuring preservation of pharma-grade Biocell API for oral and injectable applications.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Biocell flexible bags secure pharma-grade API preservation during shipping for tablets, capsules, granules, oral and injectables.
    Shipping Biocell API ships in sealed, pharma-grade flexible bags inside UN-approved, temperature-controlled packaging. Cold-chain or ambient options, desiccants, shock protection, tamper-evident labels, data loggers, and GDP/GMP documentation preserve stability, sterility, and regulatory compliance for tablet, capsule, granule, oral, and injectable applications. All shipments are handled securely from origin to destination.
    Storage Store Biocell flexible bags in original sealed packaging in a clean, dry, well-ventilated area at controlled room temperature (15–25°C). Protect from light, moisture, heat, and contamination. Keep away from incompatible materials. Do not puncture or freeze unless validated. Store upright on pallets, off the floor, follow manufacturer instructions and SDS, and maintain FIFO/FEFO rotation.
    Shelf Life Biocell shelf life: typically 2–5 years when unopened, stored dry, protected from light, at controlled temperature; confirm exact expiry with COA.
    Application of Biocell - High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable

    In oral solid dose processing, Biocell flexible bag systems are used as primary contact containment for bulk tablet cores, capsule fill, and dry granulate transfer between unit operations. The film is selected against USP <661.1> and FDA 21 CFR 211.94. Bags are supplied as 2D pillow and 3D modular formats with a contact layer of polyethylene or polyethylene-co-vinyl acetate. They are integrated into bin blender discharge, tablet press feed, and capsule filling lines. For moisture-sensitive actives, the barrier structure includes an EVOH interlayer. Water vapour transmission rate is evaluated using ISO 15106-2:2021 or equivalent. On production scale, the bags are placed inside stainless steel bins or corrugated outer boxes. The interior environment is maintained at ISO 14644-1 class 8. Emptying is performed through a bottom spout using a loss-in-weight feeder. Failure modes observed in manufacturing include pinholes at bottom discharge seams after repeated manual tie-off. This is controlled by limiting the number of cut-and-tie cycles to 5 per bag lot. The bag contact layer is not intended for use above 40°C. Published data for specific Biocell film grade is limited; supplier CoA and drug master file data are required before use.

    For injectable fill-finish lines, Biocell bags are specified as sterile single-use containers for filtered water for injection, buffer solutions, intermediate aqueous product, and final bulk drug product before aseptic filling. Bags are gamma-irradiated to a minimum dose of 25 kGy in accordance with ISO 11137-2:2013. Sterility assurance level of 10⁻⁶ is confirmed by batch sterility testing per USP <71> or Ph. Eur. 2.6.1. The bag surface is introduced into Grade A areas only after decontamination through 70% sterile isopropanol or vaporised hydrogen peroxide. Single-use aseptic connectors and tube welding maintain a closed system. Particulate emission is controlled by USP <788> limits for large-volume parenterals. Visible particles are inspected during line setup. The bags are used with peristaltic pumps or pressure vessels at ambient temperature. For temperature-sensitive biologic formulations, hold time at 2–8°C is validated by the drug product manufacturer. Biocell bags are not certified for use above 0.5 bar differential pressure unless documented by supplier. High concentrations of organic solvent may compromise the contact layer integrity; supplier compatibility data are required before such use.

    What Extractable Profile Governs Single-Use Buffer Storage at 2–8°C?

    Extractables from Biocell contact layers are evaluated according to USP <1663> and leachables according to USP <1664>. Analytical methods include headspace GC-MS for volatile organics, LC-MS for semi-volatile organics, and ICP-MS for elemental impurities. For cold buffer storage at 2–8°C, the leachable profile is typically lower than at 40°C because diffusion coefficients in the polymer matrix are reduced at low temperature. Worst-case extraction conditions are defined by the drug product manufacturer using the formulation matrix, not water alone. Typical extraction solvents include acidified water, alkaline water, 50% ethanol, and model surfactant solutions. The manufacturer may request extractable data generated under ICH Q1A(R2) stress conditions. Acceptance limits are set per PQRI parenteral and oral solid dose thresholds. No universal limit exists. TOC and NVR values are measured after autoclave or agitation extraction. Publication of the exact extractable profile for Biocell film in the public domain is limited. Suppliers provide a drug master file with product-specific data. The user must compare the extractables profile with the toxicological limit for the active pharmaceutical ingredient. For buffer storage at 2–8°C, the primary risk is migration of antioxidants and slip agents from the contact layer into high-ionic-strength solutions. Protective steps include minimising contact time and avoiding pre-rinsing with organic solvents. Bags should be filled after warming to ambient temperature at 23°C to reduce film condensation. The presence of phosphate buffer, citrate buffer, or acetate buffer at pH 3–8 is usually compatible with polyethylene-based contact layers. High pH above 9 may extract polymer additives at faster rates. For such formulations, an extractables study with a limit of quantitation of 0.1 µg/mL is advisable. Bags should be stored upright with outlet ports sealed to prevent droplet extraction from port stoppers. Validated fill volumes range from 5 L to 500 L depending on bag geometry. Published data for this specific configuration is limited. Scaling from lab-scale to production-scale requires representative surface-area-to-volume ratios. The contact layer thickness and total surface area are the two critical variables.

    Leachable Risk Control in High-Concentration Surfactant Contact

    Biocell bags used for bioreactor media containing Polysorbate 80, Polysorbate 20, or poloxamer 188 present higher leachable risk than simple buffer solutions. Surfactant molecules solubilise hydrophobic polymer additives such as erucamide, oleamide, and hindered phenolic antioxidants. Leachables are quantified by UPLC-MS with a detection limit of 0.05 µg/mL. The extraction condition should be at maximum surfactant concentration, not diluted final drug product. For cell culture media used in monoclonal antibody production, the bag may contact surfactant-containing feed for several days at 37°C. This is a severe condition. USP <665> for polymeric components used in manufacturing pharmaceutical products applies. A risk assessment should be conducted following USP <665> and ICH Q3C. The film supplier may provide an extractables profile generated in 0.5% polysorbate 80 solution at 40°C for 30 days. If not, the user must generate this data under GMP. Failure to control leachables can lead to protein aggregation in biologic drug substance. Aggregation is measured by size-exclusion chromatography. The bag contact layer is typically EVA or ULDPE, which has relatively low additive levels. However, no plastic is fully additive-free. To reduce leachable burden, the bag can be preconditioned by buffer rinse at 2–8°C for 24 hours. This removes surface-additive bloom but not bulk additives. High-concentration surfactant contact may require an alternative contact layer or fluoropolymer inner liner. The manufacturer's extractable profile should state the identity of added antioxidants. Specific limits are product-specific.

    Application AreaReference StandardTest Purpose
    Oral solid dose primary contactUSP <661.1>plastic packaging identity and biocompatibility
    Parenteral large-volume particulate controlUSP <788>subvisible particles in injectable solutions
    Sterile bag sterility testUSP <71> / Ph. Eur. 2.6.1microbial sterility confirmation
    Extractables testingUSP <1663>extractable profile from plastic systems
    Leachables testingUSP <1664>leachable assessment in drug product
    Radiation sterilisation validationISO 11137-2:2013sterilising dose establishment
    Seal integrity testingASTM F1929-15dye penetration for weld defects
    Single-use manufacturing componentsUSP <665>risk assessment for process equipment

    In cell culture fluid preservation, Biocell bags are used to freeze harvest material at –20°C or –80°C. Freezing imposes mechanical stress on the contact layer. The film must retain flexibility at low temperature. A 2D bag with a single longitudinal weld is preferred for freezing because it minimises weld seam length. Weld seams are inspected by dye penetration testing per ASTM F1929-15. Flexural cracking is a known failure mode at –80°C if the bag is dropped or folded. Bags must be placed in protective plastic shells before freezing. The freeze-thaw cycle should be controlled. A slow freeze at –20°C and thaw at 2–8°C generates large ice crystals. This may damage cells or proteins. The bag itself is not designed to protect product quality; it only contains the fluid. For investigational cell banks, cryopreservation requires cryobags with verified seal integrity at liquid nitrogen vapor phase temperatures. Published data for Biocell film at liquid nitrogen temperature is limited. The user must validate. Biocell bags are typically rated for –80°C storage but not direct immersion in liquid nitrogen. Thermal expansion of aqueous solutions is about 9–10% when freezing from 25°C to –20°C. The bag fill volume should not exceed 80% of nominal capacity to allow for expansion. Headspace gas is displaced. Port orientations should be vertical during freezing to prevent liquid ingress into filters or connectors. After thawing, the bag is drained via bottom port using a peristaltic pump. A sterile weld may be used to connect to receiving vessel.

    In high-density cell culture fluid bags, the bag may contain media, cells, and antifreeze agents such as dimethyl sulfoxide. DMSO can extract polymer additives. The user must perform leachables testing. The bag film is generally compatible with DMSO below 10% by volume. Higher DMSO content requires supplier validation. Freezing bags are often irradiated after final assembly to avoid contamination. The irradiation may increase crosslinking in polyethylene and reduce low-temperature flexibility. Mechanical tests such as ASTM D1709 dart impact may be used to compare pre- and post-irradiation film. The bag manufacturer should provide a certificate of analysis for each lot.

    When Gamma Irradiation Dose Ranges Shift from 25 kGy to 40 kGy

    Terminal sterilisation of Biocell bags by gamma irradiation is validated according to ISO 11137-1:2006 and ISO 11137-2:2013. A standard minimum dose of 25 kGy is used for pharmaceutical primary packaging. Some applications require higher minimum dose up to 40 kGy due to higher bioburden. At higher irradiation doses, the polyethylene or EVA contact layer may undergo chain scission, crosslinking, or oxidative changes. This affects mechanical strength, seal integrity, and extractables. The user must re-qualify bag performance at the maximum dose, not the minimum. Dose mapping studies are conducted with dosimeters placed at minimum and maximum zones within the load. The maximum dose can reach 50 kGy in certain areas. After irradiation, color change to yellow may occur. This is cosmetic but can be monitored by spectrophotometry. Oxygen transmission rate may increase or decrease depending on film composition. The supplier's extractables profile should include data at 40 kGy. If not, the user must generate data. High-dose irradiation can accelerate the formation of free radicals, leading to post-irradiation ageing effects. Bags should be stored in a cool, dry environment after irradiation. Revalidation of visual appearance, seal strength, and subvisible particle emission is required when shifting from 25 kGy to 40 kGy. Published data for this specific configuration is limited. The user must evaluate the bag under actual load conditions.

    Free Quote

    Competitive Biocell - High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618963613625 or mail to sales10@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618963613625

    Email: sales10@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The Biocell—High Quality Flexible Bags Ensuring Bioproducts Preservation Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable system is a multilayer flexible containment platform for active pharmaceutical ingredients in solid oral dosage and injectable supply chains. Standard fill volumes are 10 L, 25 L, 50 L, and 100 L, with coextruded film comprising a low-density polyethylene contact layer, an ethylene vinyl alcohol oxygen barrier core, and a polyamide or polyethylene terephthalate outer abuse layer. Water vapour transmission is specified not to exceed 0.05 g/(m²·day) at 23 °C and 85% RH when tested per ASTM F1249; oxygen transmission is specified below 0.01 cm³/(m²·24 h·atm) at 23 °C and 0% RH per ASTM D3985. The contact layer is formulated for compliance with USP <661.1> plastic packaging system testing and USP <661.2> polyethylene monograph requirements.

    What Film Architecture Is Used to Preserve Low-Moisture API Granules During Long-Haul Distribution?

    BC-STD grade uses a 70 µm linear low-density polyethylene contact layer, 10 µm ethylene vinyl alcohol core, 15 µm polyamide layer, and 12 µm polyethylene terephthalate exterior, including tie layers, for a total thickness of 130 µm. BC-HV grade increases the contact layer to 80 µm and the ethylene vinyl alcohol core to 15 µm, yielding a total thickness of 150 µm. BC-AM grade modifies the polyamide layer to 25 µm and total thickness to 140 µm for granule transfer under repeated flexing. Oxygen transmission for BC-HV is specified not to exceed 0.02 cm³/(m²·24 h·atm) at 23 °C and 50% RH, rising to 0.05 cm³/(m²·24 h·atm) at 85% RH because ethylene vinyl alcohol loses barrier capacity when moisture-plasticized. This humidity dependence requires secondary foil overpack when oxygen-sensitive APIs are stored in tropical distribution channels above 75% RH.

    Standard model designations are BC-STD-10, BC-STD-25, BC-STD-50, BC-STD-100, BC-HV-10 through BC-HV-100, and BC-AM-25 through BC-AM-100. Filling and discharge ports are available as DN25, DN50, and DN100 tri-clamp flanges or quick-connect nozzles. BC-HV models are supplied with double-bag overwrap and gamma-sterilized to a sterility assurance level of 10⁻⁶ per ISO 11137-1, while BC-STD and BC-AM models are supplied non-sterile with a bioburden specification below 100 CFU/bag per ISO 11737-1. Port shoulder areas are reinforced with additional film plies to reduce pinhole formation during welded-port handling.

    Biocell film grade specifications
    GradeTotal thicknessOxygen transmission at 23 °C/50% RHWater vapour transmission at 23 °C/85% RHTarget application
    BC-STD130 µm0.03 cm³/(m²·24 h·atm)0.05 g/(m²·day)tablet/capsule granule, oral API
    BC-HV150 µm0.02 cm³/(m²·24 h·atm)0.04 g/(m²·day)injectable API, frozen bulk drug substance
    BC-AM140 µm0.04 cm³/(m²·24 h·atm)0.05 g/(m²·day)high-moisture granule, abrasive powder

    Seal strength after drop shock at −20 °C does not rely on film elongation alone

    Heat sealing is performed with impulse bar equipment using controlled jaw temperature, dwell time, and pressure. Seal strength is specified at not less than 40 N/25 mm when tested per ASTM F88/F88M-21. After conditioning at −20 °C for 24 h and drop from 1.2 m onto concrete, the seal zone must retain at least 30 N/25 mm and show no dye penetration per ASTM F1929. Production-scale audits of continuous impulse sealers have identified dwell times below 1.6 s as the main cause of port-adjacent seal failures, particularly where silicone rubber jaw surfaces have aged beyond 200,000 cycles. The corrective control is replacement of silicone rubber jaw profiles at 200,000 cycles and revalidation of seal strength after each replacement. Film elongation at break is specified at ≥400% in machine direction per ASTM D882, but seal performance is governed by interlayer fusion rather than film elongation alone.

    After fluid-bed drying and milling, tablet and capsule granulations are transferred into BC-STD or BC-AM bags at product temperatures below 30 °C to avoid condensation on the inner film. The bag discharge port is coupled to a split-valve contained transfer system; because the bag collapses as product discharges, no vent filter is required, which reduces contamination entry. Electrostatic decay time is specified below 2.0 s at 12% RH per IEC 61340-2-3, allowing use with micronized APIs where static adhesion to monolayer polyethylene can exceed recovery limits. The film is rated for intermittent contact with cleaning agents including 70% isopropyl alcohol and 6% hydrogen peroxide; long-term immersion in organic solvents is not specified and published data for that configuration is limited.

    When Injectable-Grade API Requires Single-Use Containment Without Glass Delamination Risk

    BC-HV bags are used for frozen bulk injectable APIs and filter-sterilized powders. The contact layer is a low-density polyethylene formulated to avoid the delamination and sodium-leaching failure modes associated with borosilicate glass vials during long-term frozen storage. Endotoxin recovery after extraction in water for injection at 40 °C for 24 h is specified below 0.25 EU/mL; the bag is supplied with a certificate of analysis for bioburden and endotoxin. Particulate matter in product simulant is tested per USP <788> when the bag is used as a primary container for injectable bulks. Closure integrity after gamma irradiation is verified by vacuum decay per ASTM F2338-09. Unlike rigid single-use bottles, the flexible bag does not require a vent filter when draining, which reduces microbial ingress risk; however, maximum transfer pressure must not exceed 0.5 bar for BC-HV, because excess pressure can deform the port weld and create pinhole failures.

    Compared with monolayer LDPE bags, the ethylene vinyl alcohol core in Biocell reduces oxygen ingress by approximately 40-fold at 0% RH, but the benefit falls below 10-fold at 85% RH. Compared with PVC film, Biocell avoids phthalate plasticizers and is screened for extractables under USP <661.1> conditions. Compared with rigid HDPE drums, Biocell bags have lower return-shipping and warehouse volume when empty and allow collapsed discharge without air ingress; however, the bags do not provide stack-load bearing capacity above designated pallet heights and are punctured more readily by sharp tools. The bags are not compatible with autoclave steam sterilization above 121 °C because the polyester outer layer can delaminate under saturated steam; gamma irradiation within 25–40 kGy is the validated bioburden reduction method, and steam exposure should be limited to external surface pre-cleaning below 80 °C.

    Regulatory Filing Support and Extractables Documentation

    Biocell packaging documentation includes a plastic packaging system declaration and extractables study summary. The contact layer is specified to comply with USP <661.1>, USP <661.2>, and USP <87> biological reactivity tests. Cytotoxicity is tested per ISO 10993-5; sensitization and irritation data follow ISO 10993-10. Endotoxin release is controlled for BC-HV to ≤0.25 EU/mL. Heavy metals and trace-element extractables are screened per ICH Q3D guidance and USP <232>/USP <233> procedures. For injectable-grade applications, the film is supplied with a lot-specific certificate covering gamma dose range, bioburden, endotoxin, and particulate cleanliness.

    Biocell compliance documentation matrix
    RequirementStandard/methodGrade applicability
    Plastic packaging systemUSP <661.1>All
    Polyethylene monographUSP <661.2>All
    Biological reactivity in vitroUSP <87>All
    CytotoxicityISO 10993-5BC-HV
    Sterility assuranceISO 11137-1BC-HV sterile models
    BioburdenISO 11737-1BC-STD, BC-AM
    Oxygen transmissionASTM D3985All
    Water vapour transmissionASTM F1249All
    Seal strengthASTM F88/F88M-21All
    Closure integrityASTM F2338-09BC-HV

    Recommended storage of filled Biocell bags is between 15 °C and 25 °C for solid oral dosage intermediates and between −80 °C and −20 °C for frozen injectable APIs in BC-HV. Do not expose the filled bag to sustained relative humidity above 75% RH without an outer foil overpack, because ethylene vinyl alcohol oxygen barrier capacity drops with moisture plasticization. The bags are not validated for use with organic solvents such as dichloromethane, tetrahydrofuran, or N-methyl-2-pyrrolidone at concentrations above 5%, and published data for those configurations is limited. The maximum recommended conveying pressure is 0.5 bar for BC-HV and 0.3 bar for BC-STD; exceeding these limits can produce pinholes at the transition zone between the film and port shoulder. Product changeover requires disposal of the single-use bag, avoiding cross-contamination risk associated with multi-use stainless steel vessels.

    Top